|
|
Volumn 4, Issue 9, 2014, Pages
|
|
ABT-199 shows effectiveness in CLL
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4-(4-((2-(4-CHLOROPHENYL)-4,4-DIMETHYLCYCLOHEX-1-EN-1-YL)METHYL)PIPERAZIN-1-YL)-N-((3-NITRO-4-((TETRAHYDRO-2H-PYRAN-4-YLMETHYL)AMINO)PHENYL)SULFONYL)-2-(1H-PYRROLO(2,3-B)PYRIDIN-5-YLOXY)BENZAMIDE;
ANTINEOPLASTIC AGENT;
FUSED HETEROCYCLIC RINGS;
SULFONAMIDE;
HUMAN;
LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
BICYCLO COMPOUNDS, HETEROCYCLIC;
HUMANS;
LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;
SULFONAMIDES;
TREATMENT OUTCOME;
|
|
EID: 84906908155
PISSN: 21598274
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.CD-NB2014-102 Document Type: Note |
|
Times cited : (7)
|
|
References (0)
|